Trial NCT00678015

View at ClinicalTrials.gov 
Org. Study IDs: 075511

Last trial update was posted on 2014-04-09

MeSH Interventions

Masoprocol

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Prostate Cancer

Stopping Reasons

Per protocol - interim analysis showed no significant PSA declines among the first 12 patients after 3 cycles of treatment

Limitations And Caveats

Per protocol - accrual was stopped early after a pre-planned interim analysis showed no significant PSA declines after 3 cycles of treatment among the first 12 patients enrolled.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID